These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22941331)
1. Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer. Zhang D; Zhao W; Liao X; Bi T; Li H; Che X Oncol Rep; 2012 Nov; 28(5):1785-91. PubMed ID: 22941331 [TBL] [Abstract][Full Text] [Related]
2. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma. He D; Zeng Q; Ren G; Xiang T; Qian Y; Hu Q; Zhu J; Hong S; Hu G Eur J Cancer Prev; 2012 Nov; 21(6):569-75. PubMed ID: 22273848 [TBL] [Abstract][Full Text] [Related]
3. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
4. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465 [TBL] [Abstract][Full Text] [Related]
5. Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. Peng DF; Hu TL; Schneider BG; Chen Z; Xu ZK; El-Rifai W PLoS One; 2012; 7(10):e46214. PubMed ID: 23071548 [TBL] [Abstract][Full Text] [Related]
6. Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer. Wang JF; Dai DQ World J Gastroenterol; 2007 Nov; 13(43):5692-8. PubMed ID: 17963294 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368 [TBL] [Abstract][Full Text] [Related]
8. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells. Qiu C; Bu X; Jiang Z Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920 [TBL] [Abstract][Full Text] [Related]
9. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma. Sheng Y; Wang H; Liu D; Zhang C; Deng Y; Yang F; Zhang T; Zhang C Gynecol Oncol; 2016 Jan; 140(1):145-51. PubMed ID: 26597461 [TBL] [Abstract][Full Text] [Related]
10. Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer. Gong Y; Guo MZ; Ye ZJ; Zhang XL; Zhao YL; Yang YS World J Gastroenterol; 2011 Jan; 17(4):526-33. PubMed ID: 21274384 [TBL] [Abstract][Full Text] [Related]
11. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Yamashita S; Tsujino Y; Moriguchi K; Tatematsu M; Ushijima T Cancer Sci; 2006 Jan; 97(1):64-71. PubMed ID: 16367923 [TBL] [Abstract][Full Text] [Related]
12. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of FAT4 contributes to gastric field cancerization. Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292 [TBL] [Abstract][Full Text] [Related]
14. PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Yu JS; Koujak S; Nagase S; Li CM; Su T; Wang X; Keniry M; Memeo L; Rojtman A; Mansukhani M; Hibshoosh H; Tycko B; Parsons R Oncogene; 2008 Aug; 27(34):4657-65. PubMed ID: 18408767 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Li Z; Lei H; Luo M; Wang Y; Dong L; Ma Y; Liu C; Song W; Wang F; Zhang J; Shen J; Yu J Gastric Cancer; 2015 Jan; 18(1):43-54. PubMed ID: 24481854 [TBL] [Abstract][Full Text] [Related]
16. Expression of protocadherin8: Function as a tumor suppressor in hypopharyngeal carcinoma. Li Y; Liu C; Wang Z; Hu G Cancer Biomark; 2018; 22(3):495-502. PubMed ID: 29865037 [TBL] [Abstract][Full Text] [Related]
17. Role of PCDH10 and its hypermethylation in human gastric cancer. Li Z; Chim JC; Yang M; Ye J; Wong BC; Qiao L Biochim Biophys Acta; 2012 Feb; 1823(2):298-305. PubMed ID: 22206871 [TBL] [Abstract][Full Text] [Related]
18. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751 [TBL] [Abstract][Full Text] [Related]
19. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells. Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]